AXIM Biotechnologies, Inc.

AXIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
PRE 14C Aug 31, 2023 SCHEDULE 14C INFORMATION
10-Q Aug 21, 2023 AXIM BIOTECHNOLOGIES FORM 10-Q
NT 10-Q Aug 14, 2023 AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q
EFFECT Jun 9, 2023
CORRESP Jun 7, 2023
UPLOAD Jun 7, 2023
S-1 Jun 2, 2023 FORM S-1
8-K Jun 2, 2023 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
8-K May 30, 2023 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
3 May 30, 2023 PRIMARY DOCUMENT
8-K May 25, 2023 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
10-Q May 22, 2023 FORM 10-Q
NT 10-Q May 15, 2023 AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q
10-K Apr 17, 2023 FORM 10-K
NT 10-K Mar 31, 2023 AXIM BIOTECHNOLOGIES, INC. - NT 10K
8-K Jan 27, 2023 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
10-Q/A Nov 15, 2022 FORM 10-Q/A
10-Q Nov 14, 2022 FORM 10-Q
144 Oct 7, 2022
4 Sep 23, 2022 PRIMARY DOCUMENT
3 Sep 23, 2022 PRIMARY DOCUMENT
4 Sep 23, 2022 PRIMARY DOCUMENT
4 Sep 23, 2022 PRIMARY DOCUMENT
4 Sep 23, 2022 PRIMARY DOCUMENT
4 Sep 23, 2022 PRIMARY DOCUMENT
← Newer Page 2 of 13 · 306 filings Older →